Bipolar disorder involves real biological differences in the brain, but calling it a “chemical imbalance” misrepresents what researchers have actually found. The phrase implies that one neurotransmitter sits at the wrong level and that fixing it solves the problem. Decades of research point to something far messier: overlapping disruptions in neurotransmitter signaling, brain structure, stress hormones, immune function, cellular energy, and genetics, none of which reduces to a single chemical being too high or too low.
How the “Chemical Imbalance” Story Took Hold
The chemical imbalance idea gained traction in the 1960s and 1970s alongside the first effective psychiatric medications. When drugs that raised or lowered specific neurotransmitters seemed to help mood disorders, it was tempting to conclude that the disorder was simply a deficit or surplus of those chemicals. For bipolar disorder, the narrative became particularly useful as a way to frame the condition as a straightforward brain disease requiring targeted drug treatment, which helped justify expanding diagnostic categories and promoting pharmaceutical solutions.
1PubMed. The medicalisation of “ups and downs”: the marketing of the new bipolar disorderThe trouble is that this framing never had strong scientific backing. No blood test or brain scan has ever confirmed a single chemical imbalance as the cause of bipolar disorder. What researchers have found instead is that multiple biological systems behave differently in people with the condition, and these systems interact in ways that make a one-chemical explanation look almost quaint.
Dopamine’s Actual Role
If any neurotransmitter comes closest to fitting the “imbalance” story, it is dopamine. There is genuine evidence that dopamine signaling shifts between mood states. During manic or hypomanic episodes, the brain’s reward-processing circuits appear to run hot: dopamine signaling in the striatum is elevated, which tracks with the heightened energy, impulsivity, and euphoria that characterize mania.2PubMed Central. Reward processing dysfunction in major depression, bipolar disorder and schizophrenia During depressive episodes, striatal dopamine function appears dampened.3PubMed Central. The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment
Experimental evidence adds color to this picture. In one early controlled study, most participants with bipolar depression who received L-dopa, a dopamine precursor, developed hypomanic symptoms within about a week. Their symptoms faded within a day or two of stopping the drug. Amphetamines, which boost dopamine release, can similarly trigger hypomanic states in people with the condition and produce something resembling hypomania even in people without it.4PubMed Central. The Neurobiology of the Switch Process in Bipolar Disorder: a Review
But dopamine alone does not explain bipolar disorder. Plenty of people take dopamine-boosting medications without developing mania, and the shifts between mood states involve changes far beyond dopamine levels. The dopamine hypothesis is a useful piece of the picture, not the picture itself.
The Balance Between Excitation and Inhibition
A different kind of “imbalance” has drawn increasing attention: the ratio between excitatory and inhibitory neurotransmission. The brain relies on a balance between glutamate (which excites neurons into firing) and GABA (which dampens that activity). In bipolar disorder, this ratio appears to be off, though the specific direction depends on which brain region you measure and what treatment the person is receiving.
One study of people with bipolar disorder in a stable (euthymic) phase found that a key hub in the brain’s default mode network showed a higher glutamate-to-GABA ratio compared to healthy controls, driven primarily by elevated glutamate. That imbalance correlated with poorer executive function.5Psychological Medicine. Posterior cingulate and medial prefrontal excitation-inhibition balance in euthymic bipolar disorder Meanwhile, a separate study found that in a different brain region, the anterior cingulate cortex, the glutamate-to-GABA ratio was actually lower in euthymic patients taking anticonvulsants or antipsychotics. The researchers suggested this reduction might be one mechanism behind mood stabilization.6PubMed. ACC Glu/GABA ratio is decreased in euthymic bipolar disorder I patients: possible in vivo neurometabolite explanation for mood stabilization
The fact that the excitatory-inhibitory balance shifts in different directions depending on brain region and medication status illustrates why a simple “too much X, too little Y” narrative fails. The brain is not a bathtub with one faucet. Different circuits are dysregulated in different ways.
Stress Hormones and Inflammation
The biology of bipolar disorder extends well beyond neurotransmitters. The body’s stress-response system, centered on the hypothalamic-pituitary-adrenal (HPA) axis, is consistently abnormal. A meta-analysis found that people with bipolar disorder have elevated baseline cortisol and ACTH levels, with the elevations most pronounced during manic episodes.7PubMed. The HPA axis in bipolar disorder: Systematic review and meta-analysis Even during remission, the stress response appears amplified: patients in a stable mood still showed an exaggerated cortisol response to a laboratory challenge test compared to controls.8The British Journal of Psychiatry. Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder Chronically elevated cortisol can damage neurons and impair cognition over time, which may contribute to the cognitive difficulties many people with bipolar disorder experience between episodes.9PubMed. Hypothalamic-pituitary-adrenal axis and bipolar disorder
Alongside the stress system, inflammation has emerged as another consistent finding. People with bipolar disorder tend to have elevated levels of pro-inflammatory molecules in their blood, and these elevations appear during mood episodes and, to a lesser extent, between them. Intriguingly, this immune activation seems to precede the illness rather than simply result from it: genetic studies suggest the immune alterations are detectable before the onset of bipolar disorder, and people with autoimmune diseases have a higher risk of developing it.10PubMed Central. Neuroinflammation in Bipolar Depression During acute episodes, the inflammatory surge coincides with reduced levels of growth factors that support brain cell health.11PubMed Central. Bipolar Disorder: Role of Inflammation and the Development of Disease Biomarkers
Brain Wiring and Structural Changes
Neuroimaging studies show that bipolar disorder is not just about chemicals floating between neurons; the physical wiring between brain regions is different too. A recurring finding involves the connection between the prefrontal cortex, which handles planning and emotional regulation, and the amygdala, which processes emotional reactions. In people with bipolar disorder, this connection is weaker. Specifically, the prefrontal cortex exerts less top-down inhibition over the amygdala during emotional tasks.12PubMed Central. Regional fMRI hypoactivation and altered functional connectivity during emotion processing in nonmedicated depressed patients with bipolar II disorder 13PubMed Central. Frontal-amygdala connectivity alterations during emotion downregulation in bipolar I disorder In plain terms, the brain’s brake pedal for emotions does not grip as firmly.
Structural changes accumulate over time. The largest longitudinal imaging study of bipolar disorder, involving over 1,200 individuals, found faster enlargement of the brain’s fluid-filled ventricles in people with the condition, and abnormal thinning of the frontal cortex specifically in those who experienced frequent manic episodes.14PubMed. Longitudinal Structural Brain Changes in Bipolar Disorder: A Multicenter Neuroimaging Study of 1232 Individuals by the ENIGMA Bipolar Disorder Working Group Smaller studies have echoed this, finding greater gray matter loss in frontal and temporal regions in patients with recurring episodes compared to those who stayed well after a first episode of mania.15PubMed. Neuroprogression and episode recurrence in bipolar I disorder: A study of gray matter volume changes in first-episode mania and association with clinical outcome These findings have practical implications: preventing manic episodes is not just about feeling better in the short term but about protecting brain tissue from progressive damage.
Genetics and Calcium Channels
Bipolar disorder is highly heritable, but the genetics do not point to a single “bipolar gene” causing a single chemical imbalance. Instead, thousands of common genetic variants each contribute a small amount of risk. Substantial genetic overlap exists between bipolar disorder, schizophrenia, and major depression, meaning many of the same gene variants raise risk for multiple psychiatric conditions.16PubMed. Characterizing the polygenic overlaps of bipolar disorder subtypes with schizophrenia and major depressive disorder Which subtype of bipolar disorder a person develops, and which features dominate their illness, appears partly shaped by which end of this shared genetic spectrum they sit on. For example, higher polygenic risk specifically for schizophrenia is associated with more psychotic symptoms during mood episodes, while higher polygenic risk for depression is associated with comorbid anxiety.17Molecular Psychiatry. Key subphenotypes of bipolar disorder are differentially associated with polygenic liabilities for bipolar disorder, schizophrenia, and major depressive disorder
One of the most reliably identified genetic risk factors for bipolar disorder is the CACNA1C gene, which codes for a component of a calcium channel on neuron surfaces.18PubMed Central. CACNA1C (Cav1.2) in the pathophysiology of psychiatric disease This channel controls how calcium flows into cells, which in turn affects neurotransmitter release, gene expression, and the ability of synapses to strengthen or weaken over time.19PubMed Central. CACNA1C polymorphism and brain cortical structure in bipolar disorder Animal research has shown that disrupting this gene during brain development alters spontaneous calcium activity, produces abnormal brain structure, and increases anxiety-like behavior.20PubMed Central. Disrupted Cacna1c gene expression perturbs spontaneous Ca(2+) activity causing abnormal brain development and increased anxiety This is a good example of why the chemical imbalance model falls short: the genetic risk operates at the level of ion flow and cellular development, not at the level of having too much or too little of a particular brain chemical.
Cellular Energy and Growth Factors
Some of the most striking biological findings in bipolar disorder have nothing to do with neurotransmitters at all. Mitochondria, the energy-producing structures inside every cell, appear to function poorly. In postmortem brain tissue from people with bipolar disorder, the activity of a key mitochondrial enzyme complex was reduced by roughly half compared to healthy controls, a far larger reduction than seen in major depression and absent in schizophrenia.21JAMA Psychiatry. Mitochondrial Complex I Activity and Oxidative Damage to Mitochondrial Proteins in the Prefrontal Cortex of Patients With Bipolar Disorder The same tissue showed elevated markers of oxidative damage, suggesting that struggling mitochondria leak harmful byproducts that damage surrounding proteins. Beyond energy production, mitochondrial dysfunction in bipolar disorder has been linked to abnormal calcium handling, glutamate toxicity, and shifts toward programmed cell death.22PubMed Central. Mitochondrial dysfunction as a critical event in the pathophysiology of bipolar disorder
Growth factors tell a parallel story. BDNF, a protein that supports the survival and growth of neurons, drops during both manic and depressive episodes and returns toward normal during stable periods.23PubMed Central. The role of BDNF as a mediator of neuroplasticity in bipolar disorder 24PubMed. Alterations in BDNF (brain derived neurotrophic factor) and GDNF (glial cell line-derived neurotrophic factor) serum levels in bipolar disorder: The role of lithium This pattern suggests that mood episodes are not merely unpleasant experiences but periods during which the brain’s capacity for self-repair is actively diminished, helping explain why repeated episodes can cause lasting cognitive effects.
Circadian Rhythms and Internal Clocks
Sleep disruption is one of the most reliable triggers for mood episodes in bipolar disorder, and the underlying biology appears to go deeper than just losing sleep. The body’s internal clock, the circadian system, is fundamentally altered. Multiple clock genes, the genes that govern 24-hour biological rhythms, have been linked to bipolar disorder risk.25PubMed Central. Bipolar Disorder, Circadian Rhythm and Clock Genes Patients show abnormal patterns in the secretion of melatonin and cortisol, two hormones whose daily rhythms are driven by the brain’s master clock. These disrupted rhythms appear to desynchronize the body’s central and peripheral clocks, potentially triggering or worsening mood episodes.26Frontiers in Psychiatry. Circadian rhythm disruptions: A possible link of bipolar disorder and endocrine comorbidities
This dimension of the biology matters for everyday management. Keeping a regular sleep-wake schedule is one of the most effective behavioral strategies for preventing mood episodes, and it works precisely because it helps stabilize a circadian system that is inherently fragile in people with bipolar disorder. Framing the condition as a “chemical imbalance” obscures this practical insight and channels attention exclusively toward medication.
What Medications Reveal About the Biology
If bipolar disorder were a simple chemical imbalance, you would expect medications to work by correcting that one chemical. Instead, the drugs that treat bipolar disorder act on a bewildering array of biological targets. Lithium, the oldest and still most effective mood stabilizer, does not primarily adjust neurotransmitter levels. Its major known actions include inhibiting an enzyme called GSK-3β, activating a developmental signaling pathway that promotes new neuron growth, and modulating intracellular signaling cascades that control inflammation, cell survival, and synaptic resilience.27Frontiers in Molecular Neuroscience. GSK-3 and Wnt Signaling in Neurogenesis and Bipolar Disorder 28PubMed Central. Second messenger/signal transduction pathways in major mood disorders: moving from membrane to mechanism of action, part II: bipolar disorder
Valproate, another commonly used mood stabilizer, works through different primary targets altogether: it enhances the inactivation of sodium channels to reduce rapid neuronal firing and indirectly boosts GABA function. Lamotrigine blocks both sodium channels and L-type calcium channels while also reducing glutamate release.29Trends in Neurosciences. Neurobiological mechanisms of mood-stabilizing drugs Both valproate and lamotrigine also speed up the clearance of glutamate from synapses, dampening excitatory signaling by a side route rather than by directly blocking glutamate receptors. The fact that three effective medications work through three largely different primary mechanisms tells you there is no single chemical lever that explains the disorder.
Environmental Triggers and Epigenetics
Genes load the gun; environment pulls the trigger, as the saying goes. Childhood trauma stands out as a particularly potent environmental factor. People who carry genetic susceptibility and experience significant trauma are at elevated risk for developing bipolar disorder and for having a more severe course once it emerges. The interaction between certain genes, especially those involved in serotonin transport and stress-hormone regulation, and early-life adversity produces lasting changes in brain function through epigenetic mechanisms such as DNA methylation, which can alter gene activity for years or decades without changing the underlying genetic code.30PubMed. Childhood trauma in mood disorders: Neurobiological mechanisms and implications for treatment
Trauma also appears to act through BDNF, the growth factor discussed earlier. People who carry a particular variant of the BDNF gene and who have experienced trauma show reduced BDNF function from multiple converging sources, including the genetic variant itself, trauma-induced epigenetic suppression, and ongoing stress.31PubMed Central. BDNF function as a potential mediator of bipolar disorder and post-traumatic stress disorder comorbidity This kind of gene-environment interplay cannot be captured by a phrase as blunt as “chemical imbalance.”
The Microbiome Connection
One of the newer frontiers in bipolar disorder research involves the gut. The trillions of bacteria living in the intestinal tract communicate with the brain through immune signaling, hormone production, and the vagus nerve. When this microbial ecosystem falls out of balance, the resulting inflammation and changes in gut-barrier function can activate the HPA stress axis and alter neurotransmitter metabolism in the brain.32Molecular Psychiatry. Microbiota–gut–brain axis mechanisms in the complex network of bipolar disorders: potential clinical implications and translational opportunities People with bipolar disorder consistently show differences in gut microbial composition compared to healthy controls, though researchers are still working out whether these differences are a cause, a consequence, or a feedback loop.
This line of research is still early. No probiotic regimen has proven effective as a stand-alone treatment for bipolar disorder, and the studies are mostly observational. But the gut-brain axis illustrates the broader point: bipolar disorder involves the whole body, not just a neurotransmitter dial turned to the wrong setting.
Why No Biomarker Exists Yet
Given the number of biological systems involved, you might expect that at least one reliable biomarker, a measurable indicator that a person has bipolar disorder, would have emerged by now. None has. Diagnosis still rests entirely on clinical observation of symptoms and their patterns over time.33PubMed Central. The Discovery of Clinically Applicable Biomarkers for Bipolar Disorder: A Review of Candidate and Proteomic Approaches The search based on single hypotheses, like looking for a specific neurotransmitter abnormality, has not panned out, and the field is increasingly turning toward broader technologies that measure many biological signals simultaneously.
Some researchers have gone further, arguing that the lack of a unifying biological cause reflects something fundamental about what psychiatric disorders are. Rather than being the expression of a single underlying disease process the way a tumor causes headaches, bipolar disorder may be better understood as a network of interacting symptoms that reinforce each other, with the collection of symptoms essentially constituting the disorder itself.34PLOS ONE. A Network Approach to Bipolar Symptomatology in Patients with Different Course Types Under this view, asking “what causes bipolar disorder” is a bit like asking “what causes traffic”: there is no single cause, but a set of conditions that interact to produce a recognizable pattern. That perspective does not make the biology less real. It just means the biology is distributed across many systems, and the phrase “chemical imbalance” captures approximately none of that complexity.